I break down Richardson, et al. NEJM DETERMINATION
Transplanters are determined to keep going, should they be?

Watch the videos b/c I have lots of great visuals
My ASCO Coverage continues

4.64 - DETERMINATION - Should we still use transplant Myeloma?

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Patient advocates, Pharma funding, and is MRD a suitable endpoint

Patient advocates funded by Pharma

FDA makes MRD the basis for AA

Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".

Beta Blockers After Heart Attacks Don't Work

Blood based and Stool DNA colon cancer screening - Two NEJM papers

Another flawed study Keynote 564. Pembro in adjuvant RCC

4.64 - DETERMINATION - Should we still use transplant Myeloma?

Download our free app to listen on your phone